Innovana Thinklabs Ltd

AGM Details

• Date and time: Sep 29, 2026, 11:30 AM–1:00 PM IST.
• Mode: Physical meeting at the registered office in Jaipur.

Key Resolutions

• Adoption of financial statements (standalone and consolidated) – Ordinary – Passed.
• Re-appointment of Kapil Garg as director liable to retire by rotation – Ordinary – Passed.
• Material related party transaction limits with Bitguardian GmbH – Special – Passed.
• Material related party transaction limits with Digital Protection Services SRL – Special – Passed.

Voting Outcome

• All resolutions passed by requisite majority; no material dissent reported.

Directors & Auditors

• Kapil Garg re-appointed as director; liable to retire by rotation.
• No auditor appointments or changes reported.

Related Party Transactions

• Bitguardian GmbH: limits approved; value not disclosed.
• Digital Protection Services SRL: limits approved; value not disclosed.

AGM Details

• AGM held Sept 29, 2026 at 11:30 AM at the registered office, Jaipur.
• Remote e-voting from Sept 26–28, 2026; physical voting at AGM.
• Quorum details: 27 members present in person or via proxy.

Key Resolutions (Ordinary)

• Adopt standalone and consolidated financial statements for FY2025-26.
• Approve material related party transaction limits with Bitguardian GMBH.
• Approve material related party transaction limits with Digital Protection Services SRL.

Voting Status

• Voting results to be announced separately; not disclosed in filing.

Director Changes

• Director re-appointment by rotation: Kapil Garg.

Innovana Thinklabs Limited — Closure of Trading Window from Thursday, October 01, 2026 till the expiry of 48 hours after the declaration of Un-audited Standalone and Consolidated Financial results of the Company for the quarter and half year ending September 30, 2026

Key approvals and AGM planning

• Board approved the Board Report for the financial year ended 31 March 2026.
• Convening of the 11th AGM on 29 September 2026 approved.
• Notice of 11th AGM approved; Mr. Abhishek Goswami, Practicing Company Secretary (C.P. No. 17057), appointed Scrutinizer for e-voting.

Use of funds and deviation status

• Fundraising mode: preferential issue of convertible warrants.
• Proceeds disclosed; exact amount and subsequent payments details summarized in filing.
• Audit Committee: no deviations observed in utilisation of proceeds.
• Monitoring agency: not applicable.
• Original allocation to general corporate purposes; no modification or deviation.
• Utilisation status: no deviation; proceeds utilised as per stated objects.

Financial results and publication

• Approved the unaudited standalone and consolidated results for quarter ended 30 June 2026.
• Limited Review Reports on both results were taken on record.
• Results to be published in newspapers; available on the company website.
• Trading Window open 48 hours after results declaration.

Auditors and governance disclosures

• Independent auditor’s review reports issued; no material misstatement observed.
• Audit Committee reviewed and recommended the consolidated and standalone results.
• Statutory auditors issued unmodified Limited Review Report.

Fundraising and use of funds

• Annexure reports no deviation in utilization of funds raised via convertible warrants.
• Minimum funds raised: Rs 9.265 crore; balance due on exercise.
• Rs 5.172 crore received through warrant conversion.
• Original object: General Corporate Purposes; remaining proceeds expected within 18 months.
• No investor complaints pending as of 30 June 2026.

Regulatory and disclosures

• Results available on NSE/BSE portals and company website.
• Note: 30 June 2026 filing prepared under SEBI Regulations; details enclosed.

Meeting Details

• Date of board meeting: Thursday, August 13, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Other Notes

• Trading window closed from July 1, 2026; reopens 48 hours after results declaration.

Dematerialisation status

• Regulation 74(5) certificate enclosed; excerpt contains no processing, listing, or mutilation details.